Insights

Platform Scale Position Deep Genomics as a partner to scale their Biological Foundation Models by offering end-to-end MLOps, cloud deployment on Azure, data curation, and lab-in-the-loop workflow integration to accelerate model refinement and drug discovery timelines.

Data & Models Provide advanced data management, training dataset pipelines, and AI output dataset asset governance to help refine their BioFM models and improve reproducibility.

Enterprise Integration Offer NetSuite native integrations and broader enterprise tooling to streamline budget, procurement, project tracking, and cross-team collaboration on AI biology programs.

RNA Focus Target opportunities around BigRNA, DeepADAR, and REPRESS by offering validation services, assay development, data pipelines for RNA biology, and screening capabilities that help customers de-risk RNA-targeted therapeutics.

Strategic Partnerships With leadership changes including new CEO and board appointments, pursue high-value strategic alliances with pharma, biotech, and CROs for joint development, pilots, and long-term collaborations to scale translational programs.

Deep Genomics Tech Stack

Deep Genomics uses 8 technology products and services including Kubeflow, NetSuite, Keras, and more. Explore Deep Genomics's tech stack below.

  • Kubeflow
    Dev Tools
  • NetSuite
    E-commerce
  • Keras
    Machine Learning
  • Microsoft Windows
    Operating Systems
  • Bash
    Operating Systems & Computing Languages
  • Microsoft Azure
    Platform As A Service
  • C++
    Programming Languages
  • Python
    Programming Languages

Media & News

Deep Genomics's Email Address Formats

Deep Genomics uses at least 1 format(s):
Deep Genomics Email FormatsExamplePercentage
First@deepgenomics.comJohn@deepgenomics.com
78%
First.Last@deepgenomics.comJohn.Doe@deepgenomics.com
16%
Last@deepgenomics.comDoe@deepgenomics.com
6%

Frequently Asked Questions

What is Deep Genomics's official website and social media links?

Minus sign iconPlus sign icon
Deep Genomics's official website is deepgenomics.com and has social profiles on LinkedInCrunchbase.

What is Deep Genomics's SIC code NAICS code?

Minus sign iconPlus sign icon
Deep Genomics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Deep Genomics have currently?

Minus sign iconPlus sign icon
As of July 2026, Deep Genomics has approximately 108 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: B. F.Chief Operating Officer: T. M.Chief Business Officer: C. B.. Explore Deep Genomics's employee directory with LeadIQ.

What industry does Deep Genomics belong to?

Minus sign iconPlus sign icon
Deep Genomics operates in the Biotechnology Research industry.

What technology does Deep Genomics use?

Minus sign iconPlus sign icon
Deep Genomics's tech stack includes KubeflowNetSuiteKerasMicrosoft WindowsBashMicrosoft AzureC++Python.

What is Deep Genomics's email format?

Minus sign iconPlus sign icon
Deep Genomics's email format typically follows the pattern of First@deepgenomics.com. Find more Deep Genomics email formats with LeadIQ.

How much funding has Deep Genomics raised to date?

Minus sign iconPlus sign icon
As of July 2026, Deep Genomics has raised $237M in funding. The last funding round occurred on Jul 28, 2021 for $180M.

When was Deep Genomics founded?

Minus sign iconPlus sign icon
Deep Genomics was founded in 2014.
Deep Genomics logo

Deep Genomics

Biotechnology ResearchOntario, Canada51-200 Employees

Deep Genomics is a biotechnology research company based in Toronto, Ontario, Canada, with 51 to 200 employees. It focuses on solving molecular design and target biology problems by integrating lab-in-the-loop workflows with artificial intelligence through its Biological Foundation Models platform (BioFM). The BioFM platform provides a unified architecture for AI model development and refinement, fit-for-purpose training datasets, AI output dataset assets, screening technologies, and supporting information and software systems to accelerate drug-discovery activities. The company collaborates across disciplines to address problems that have historically required slow empirical iteration. It has launched RNA-focused AI foundation models such as BigRNA, along with related models including DeepADAR and REPRESS, and has announced governance updates involving board appointments.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $237M

    Deep Genomics has raised a total of $237M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a series_c.

  • $25M$50M

    Deep Genomics's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $237M

    Deep Genomics has raised a total of $237M of funding over 6 rounds. Their latest funding round was raised on Jul 28, 2021 in the amount of $180Mas a series_c.

  • $25M$50M

    Deep Genomics's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.